|
Day +305 and we have had more interesting developments from the results of BMB 8 days ago. This BMB followed two cycles of Vidaza (post relapse at about Day 230).
The first report, "Leukemia Markers-Bone Marrow",indicated "No morphologigic or immunophenotypic evidence of residual acute myeloid leukemia". Additionally, "No increase in blasts (less than 5 percent). And, "No circulating blasts".
Second report, "Engraftment Post Transplant, Bone Marrow" ... "No host cells detected".
I am really surprised that the Vidaza and Sprycel could turn this situation around this quickly after just two cycles. Or, could something else be going on? Naturally this could be a temporary development, but we are very willing to take any good news available. The doctors have lengthened my Vidaza cycles to five weeks (7+28 days).
__________________
age 70, dx RAEB-2 on 11-26-2013 w/11% blasts. 8 cycles Vidaza 3w/Revlimid. SCT 8/15/2014, relapsed@Day+210 (AML). Now(SCT-Day+1005). Prepping w/ 10 days Dacogen for DLI on 6/9/2017.
|